<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03627650</url>
  </required_header>
  <id_info>
    <org_study_id>EC 2010/ 572</org_study_id>
    <nct_id>NCT03627650</nct_id>
  </id_info>
  <brief_title>Fat Grafting in Skin-grafted Deep Burn Scars</brief_title>
  <official_title>Fat Grafting in Immature Skin-grafted Burn Scars: a Randomised Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      fat grafting in human skin-grafted immature burn scars histological, clinical and
      photographic follow-up
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: A randomised clinical trial was performed to determine the effect of autologous
      fat grafting on scar formation in early skin-grafted deep burn wounds.

      Methods: Included patients received split-thickness skin grafting procedures for deep burn
      wounds less than 3 months ago. A homogenous scar area in each patient was divided into two
      equal parts. One part was treated with transcutaneous sharp needle autologous fat grafting,
      the adjacent part with transcutaneous saline injection as control. Results were evaluated by
      clinical assessment with scar scale questionnaires, histological examination, and objective
      scar assessment with Cutometer, Mexameter, Tewameter and Corneometer.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2013</start_date>
  <completion_date type="Actual">October 1, 2016</completion_date>
  <primary_completion_date type="Actual">September 10, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomised controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>2 skin zones per participant, A and B, 1 is treated, 1 is placebo coin toss determines which zone will be treated, this information is kept in sealed envelope</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of scar quality by histological assessment</measure>
    <time_frame>6 months</time_frame>
    <description>histology of scar tissue, scoring by 2 independent blinded anatomopathologists, (numerical scoring of fibroblast activity, collagen and elastin organisation, vascularity) scoring range min 1(close to normal tissue) - 3 (scar characteristics)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>improvement of scar quality by physiological testing with cutometer</measure>
    <time_frame>6 months, 1 year</time_frame>
    <description>measures elasticity of the scar; micrometer; higher values better outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement of scar quality by subjective evaluation with numerical Vancouver Scar Scale</measure>
    <time_frame>1 year</time_frame>
    <description>numerical score 0 to 13; ranges vascularity, height/thickness, pliability, and pigmentation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement of scar quality by subjective evaluation with numerical POSAS (Patient and Observer Scar Assessment Scale) Scale</measure>
    <time_frame>1 year</time_frame>
    <description>numerical score 5 to 50: VSS plus surface area; patient assessments of pain, itching, color, stiffness, thickness, relief</description>
  </primary_outcome>
  <primary_outcome>
    <measure>improvement of scar quality by physiological testing with TEWA-meter (Trans Epidermal Water Loss-meter)</measure>
    <time_frame>6 months, 1 year</time_frame>
    <description>measures transepidermal water loss; g/m2/h; higher values worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>physiological testing of scar tissue by corneometer</measure>
    <time_frame>6 months, 1 year</time_frame>
    <description>measures hydration of the epidermis; corneometer units, higher values better outcome</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Burn Scar</condition>
  <arm_group>
    <arm_group_label>1 group of 15 patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>procedure/surgery: fat grafting injection of scar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Same group of 15 patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>procedure/surgery: placebo injection of scar</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>lipofilling/ fat grafting</intervention_name>
    <description>liposuction, processing/ cleaning of fat tissue; reinjection with sharp needle transcutaneous</description>
    <arm_group_label>1 group of 15 patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>placebo injection</intervention_name>
    <arm_group_label>Same group of 15 patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  early skin-grafted deep burn scars

          -  otherwise healthy

        Exclusion Criteria:

          -  concomitant disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maarten AJ Doornaert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UGent University Hospital</affiliation>
  </overall_official>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>October 6, 2017</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2018</study_first_posted>
  <last_update_submitted>August 18, 2018</last_update_submitted>
  <last_update_submitted_qc>August 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Ghent</investigator_affiliation>
    <investigator_full_name>Phillip Blondeel</investigator_full_name>
    <investigator_title>Clinical Professor, Head of Plastic Surgery, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>burn</keyword>
  <keyword>scar</keyword>
  <keyword>fat</keyword>
  <keyword>grafting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cicatrix</mesh_term>
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

